Flecainide acetate and Rythmol drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Flecainide acetate (flecainide acetate) and Rythmol (propafenone hydrochloride). Common drug interactions include diarrhoea among females and atrial tachycardia among males.

The phase IV clinical study analyzes what interactions people have when they take Flecainide acetate and Rythmol. It is created by eHealthMe based on reports of 20 people who take the same drugs from the FDA, and is updated regularly.

What is Flecainide acetate?

Flecainide acetate has active ingredients of flecainide acetate. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 7,176 Flecainide acetate users. Check the latest studies of Flecainide acetate.

What is Rythmol?

Rythmol has active ingredients of propafenone hydrochloride. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 3,638 Rythmol users. Check the latest studies of Rythmol.



On Jul, 04, 2026

20 people who take Flecainide acetate and Rythmol together, and have interactions are studied.

Flecainide acetate and Rythmol drug interactions.

What are the common drug interactions of Flecainide Acetate and Rythmol, by gender? *:

female:

  1. Diarrhoea
  2. Balance disorder
  3. Nausea (feeling of having an urge to vomit)
  4. Vomiting
  5. Abdominal distension
  6. Abdominal pain
  7. Ankle fracture
  8. Aortic arteriosclerosis (hardening of the aortic arteries)
  9. Aortic stenosis (obstruction to the outflow of blood from the left ventricle into the aorta)
  10. Asthenia (weakness)

male:

  1. Atrial tachycardia (rhythm disturbance that arises in the atria)
  2. Bundle branch block left (absence of transmission of electric impulses from the atrioventricular (av) bundle of his to the left ventricle)
  3. Cardiac disorder
  4. Clonus (series of involuntary, rhythmic, muscular contractions and relaxations)
  5. Dystonia (abnormal muscle tone)
  6. Headache (pain in head)
  7. Ill-defined disorder
  8. Lupus-like syndrome (a disease symptom matches with lupus an immune disease)
  9. Pneumocystis jiroveci pneumonia (fungal infection of the lungs)
  10. Respiratory disorder (respiratory disease)

What are the common drug interactions of Flecainide Acetate and Rythmol, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Atrial tachycardia (rhythm disturbance that arises in the atria)
  2. Bundle branch block left (absence of transmission of electric impulses from the atrioventricular (av) bundle of his to the left ventricle)
  3. Ventricular tachycardia (rapid heartbeat that originates in one of the lower chambers (the ventricles) of the heart)
  4. Atrioventricular block (heart block)
  5. Atrioventricular block complete (heart block complete)
  6. Bundle branch block (disruption in the normal flow of electrical pulses that drive the heart beat)
  7. Overdose
  8. Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)
  9. Syncope (loss of consciousness with an inability to maintain postural tone)

60+:

  1. Diarrhoea
  2. Balance disorder
  3. Abdominal distension
  4. Abdominal pain
  5. Ankle fracture
  6. Aortic arteriosclerosis (hardening of the aortic arteries)
  7. Aortic stenosis (obstruction to the outflow of blood from the left ventricle into the aorta)
  8. Asthenia (weakness)
  9. Atrioventricular block first degree (heart block first degree)
  10. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)

What are the existing conditions these people have? *

  1. High Blood Pressure: 4 people, 20.00%
  2. Arrhythmias (irregular heartbeat): 3 people, 15.00%
  3. High Blood Cholesterol: 3 people, 15.00%
  4. Insomnia (sleeplessness): 2 people, 10.00%
  5. Arthropathy: 2 people, 10.00%
  6. Asthma: 2 people, 10.00%
  7. Chest Pain: 2 people, 10.00%
  8. Colitis (inflammation of colon): 2 people, 10.00%
  9. Cough: 2 people, 10.00%
  10. Depression: 2 people, 10.00%

* Approximation only. Some reports may have incomplete information.

Do you take Flecainide acetate and Rythmol?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Flecainide acetate and Rythmol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Flecainide acetate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Rythmol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Flecainide acetate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Rythmol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on flecainide acetate and propafenone hydrochloride (the active ingredients of Flecainide acetate and Rythmol, respectively), and Flecainide acetate and Rythmol (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: